High Court finds Sandoz infringed Lundbeck’s Lexapro patent

Angus Lang 2022-03-09 4:40 pm By Miklos Bolza | Sydney

Please login to bookmark

The High Court has found that Novartis unit Sandoz infringed Danish drug company Lundbeck’s patent for its blockbuster antidepressant Lexapro, but has overturned a ruling that found the generic drug maker owes $26.3 million in damages.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au